Industry News
Study of leukemias in children living close to heavily used roads
9/18/2015
Inserm researchers from CRESS (Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, INSERM - Paris Descartes University - University of Paris 13 - Paris Diderot University - INRA)...
Cancer doesn't sleep: Myc oncogene disrupts clock and metabolism in cancer cells
9/18/2015
Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of...
Biomarker may predict who'll benefit from targeted therapy for HER2-negative breast cancer
9/18/2015
A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond -- and which should switch to...
Study finds high proportion of advanced breast cancers in sub-Saharan Africa
9/18/2015
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d'Ivoire and Republic of Congo are detected only after they've become advanced.
New prostate cancer screening review article advocates for active surveillance
9/18/2015
In the wake of changing guidelines related to prostate cancer screening, a newly published review article out of University Hospitals Case Medical Center's Seidman Cancer Center in Cleveland...
Molecular imaging study reveals improved detection of early recurrent prostate cancer
9/18/2015
A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine.
Vaccine clears some precancerous cervical lesions in clinical trial
9/18/2015
Scientists have used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial.
Molecular imaging study reveals improved detection of early recurrent prostate cancer
9/18/2015
A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine.
Vaccine clears some precancerous cervical lesions in clinical trial
9/18/2015
Scientists have used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial.
Discovery of a triple barrier that prevents cells from becoming cancerous
9/18/2015
Universitat Autònoma de Barcelona researchers have identified for the first time the triple mechanism that stops chromosome separation in response to situations that compromise the integrity of...